Harvard Bioscience (HBIO) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.07% |
| Dec 31, 2025 | 0.70% |
| Sep 30, 2025 | 19.43% |
| Jun 30, 2025 | 23.13% |
| Mar 31, 2025 | -1.17% |
| Dec 31, 2024 | -13.19% |
| Sep 30, 2024 | -7.77% |
| Jun 30, 2024 | -3.88% |
| Mar 31, 2024 | -3.29% |
| Dec 31, 2023 | -12.12% |
| Sep 30, 2023 | -4.32% |
| Jun 30, 2023 | -5.12% |
| Mar 31, 2023 | -8.76% |
| Dec 31, 2022 | -4.69% |
| Sep 30, 2022 | -2.49% |
| Jun 30, 2022 | -2.05% |
| Mar 31, 2022 | 3.39% |
| Dec 31, 2021 | 6.92% |
| Sep 30, 2021 | 0.75% |
| Jun 30, 2021 | 11.43% |
| Mar 31, 2021 | 6.85% |
| Dec 31, 2020 | 4.28% |
| Sep 30, 2020 | -14.36% |
| Jun 30, 2020 | -15.47% |
| Mar 31, 2020 | -6.04% |
| Dec 31, 2019 | -10.02% |
| Sep 30, 2019 | -23.85% |
| Jun 30, 2019 | -28.52% |
| Mar 31, 2019 | -27.91% |
| Dec 31, 2018 | -20.52% |
| Sep 30, 2018 | -20.28% |
| Jun 30, 2018 | -31.37% |
| Mar 31, 2018 | -24.08% |
| Dec 31, 2017 | -22.63% |
| Sep 30, 2017 | -22.06% |
| Jun 30, 2017 | -24.02% |
| Mar 31, 2017 | -23.77% |
| Dec 31, 2016 | -20.76% |
| Sep 30, 2016 | -19.93% |
| Jun 30, 2016 | -30.09% |
| Mar 31, 2016 | -26.96% |
| Dec 31, 2015 | -19.30% |
| Sep 30, 2015 | -18.77% |
| Jun 30, 2015 | -17.27% |